| Dec 25 | |
|---|---|
| Income Statement | |
| Total Revenue | $ 0.00 |
| Gross Profit | $ 0.00 |
| Operating Income | $ -4.90M |
| EBITDA | $ -4.90M |
| Net Income | $ -5.86M |
| Balance Sheet | |
| Cash & Short-Term Investments | $ 4.29M |
| Total Assets | $ 5.00M |
| Total Debt | $ 118.00K |
| Net Debt | $ -1.12M |
| Total Liabilities | $ 2.24M |
| Stockholders' Equity | $ 2.77M |
| Cash Flow | |
| Free Cash Flow | $ -4.93M |
| Operating Cash Flow | $ -4.92M |
| Investing Cash Flow | $ -3.01M |
| Financing Cash Flow | $ 8.92M |
Nasus Pharma Ltd. (NSRX)
:NSRX
